Henry Schein, Inc. operates through a centralized and automated distribution network, with a selection of more than 300,000 health care products that support health care around the globe. The Company’s network of trusted advisors provides more than 1 million customers globally with valued solutions that improve operational success and clinical outcomes.
Henry Schein, Inc. is working to help address the shortages of PPE (personal protective equipment) caused by the COVID-19 pandemic. The Company is dedicated to getting more product into the hands of those who need it most—health care professionals.
The pictured antibody rapid blood test measures the presence of antibodies associated with the 2019 novel coronavirus (SARS-CoV-2) in blood drawn with a pinprick. The test can help assess the likelihood of past and present infections. Along with other information, such as the presence of symptoms, the tests may help health care professionals assess whether individuals (including health care workers) have recovered from the virus.
Henry Schein, Inc. also announced the availability of an antibody rapid blood test, known as Standard Q COVID-19 IgM/IgG Rapid Test, intended to be administered at the point of care. The test delivers results within 15 minutes from a pinprick with no instrumentation required.
“Henry Schein is committed to providing health care professionals with quality products they can rely on to care for patients,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “Henry Schein has played a key role in providing point-of-care testing to health care professionals, and is now responding to the urgent need for wide availability of rapid point-of-care testing for COVID-19. This pandemic is an unprecedented situation, and making rapid diagnostic tools available to health care professionals is critical for detecting and mitigating the spread of the coronavirus.”
Health care professionals can use the results of the test, along with a patient’s medical history, symptoms, and results of other relevant testing, to make informed decisions about patient treatment and care. Henry Schein, Inc. is working through multiple channels to distribute the tests in the U.S. as quickly as possible in response to the urgent need for rapid, accurate testing. The Company’s initial focus will be supplying the tests to health care professionals.
Henry Schein, Inc. is the private-sector lead of the Pandemic Supply Chain Network, a public-private partnership created in 2015 to improve the efficiency of the PPE supply chain. Through this network, Henry Schein, Inc. is advocating to ease the global supply chain so that product can begin to flow again.
The Company also launched a COVID-19 Resource Center that features a collection of links and downloadable infographics to help health care professionals prepare and effectively communicate with their staff and patients as the outbreak continues to evolve.
Read ongoing updates from Henry Schein, Inc. on the Company’s response to COVID-19.